NasdaqGM - Nasdaq Real Time Price USD

ArriVent BioPharma, Inc. (AVBP)

Compare
29.16 +0.17 (+0.59%)
At close: October 18 at 4:00 PM EDT
29.16 0.00 (0.00%)
After hours: October 18 at 4:02 PM EDT
Currency in USD All numbers in thousands
Breakdown
TTM
12/31/2023
12/31/2022
Operating Expense
86,205.00
74,590.00
36,906.00
Operating Income
-86,205.00
-74,590.00
-36,906.00
Net Non Operating Interest Income Expense
11,320.00
5,257.00
--
Pretax Income
-74,885.00
-69,333.00
-36,906.00
Net Income Common Stockholders
-74,885.00
-69,333.00
-36,906.00
Diluted NI Available to Com Stockholders
-74,885.00
-69,333.00
-36,906.00
Basic EPS
-2.23
-2.17
-1.15
Diluted EPS
-2.23
-2.17
-1.15
Basic Average Shares
33,509.09
31,956.66
31,956.66
Diluted Average Shares
33,509.09
31,956.66
31,956.66
Total Operating Income as Reported
-86,205.00
-74,590.00
-36,906.00
Total Expenses
86,205.00
74,590.00
36,906.00
Net Income from Continuing & Discontinued Operation
-74,885.00
-69,333.00
-36,906.00
Normalized Income
-74,885.00
-69,333.00
-36,906.00
Interest Income
11,320.00
5,257.00
--
Net Interest Income
11,320.00
5,257.00
--
EBIT
-86,205.00
-74,590.00
-36,906.00
EBITDA
-86,205.00
-74,590.00
-36,906.00
Net Income from Continuing Operation Net Minority Interest
-74,885.00
-69,333.00
-36,906.00
Normalized EBITDA
-86,205.00
-74,590.00
-36,906.00
12/31/2022 - 1/26/2024

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers